Advanced biomedical research · 2025
Identification of Candidate Inhibitors to SARS-CoV-2's Enzymes and Potential Disruptors of Its Structural Proteins' Interactions.
СтатьяНазвание и аннотация: Перевод в очереди
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Mohammadian Ali, Jadaliha Mahdieh, Imanpour Aylar, Pourvali Moghadam Hamed, Jahangir AmirHossein
Аннотация
BACKGROUND: Many studies have assessed the possible inhibitors for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). However, experiences like that from human immunodeficiency virus have taught us that a multidrug approach will reduce the chance of viral resistance.
MATERIALS AND METHODS: Here, we screened 2371 Food and Drug Administration-approved drugs for possible inhibition of nonstructural proteins of SARS-CoV-2 and expanded the work to include ligands that might interfere with the roles of structural proteins. Three different algorithms were used and suggested hits obtained using qVina were verified using Autodock Vina and leDock software.
RESULTS: Our results suggest direct-acting antivirals against hepatitis C might be efficient against SARS-CoV-2.
CONCLUSIONS: Drug repurposing is a promising approach for the rapid identification of potential treatments for emerging diseases such as coronavirus disease.
MATERIALS AND METHODS: Here, we screened 2371 Food and Drug Administration-approved drugs for possible inhibition of nonstructural proteins of SARS-CoV-2 and expanded the work to include ligands that might interfere with the roles of structural proteins. Three different algorithms were used and suggested hits obtained using qVina were verified using Autodock Vina and leDock software.
RESULTS: Our results suggest direct-acting antivirals against hepatitis C might be efficient against SARS-CoV-2.
CONCLUSIONS: Drug repurposing is a promising approach for the rapid identification of potential treatments for emerging diseases such as coronavirus disease.